Key facts
- This page summarizes Joseph Tung's Form 4 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2025, 21:23.
Joseph Tung - 08 Aug 2025 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Reporting relationship
- Director
- Issuer ticker
- SHPH
- Reported as of
- 08 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2025, 21:23:42 UTC
- Prior SEC filing
- 09 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Tung
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph Tung filed Form 4 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 12 Aug 2025.
Change
- Previous filing in this sequence was filed on 09 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002060609
Primary reporting owner
Tung Joseph
- Relationship
- Director
- Address
- C/O SHUTTLE PHARMACEUTICALS HOLDINGS, 401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG
- Signature
- /s/ Joseph Tung
- Signature date
- 12 Aug 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SHPH
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +29,240
- Change %
- Price
- $0.000000
- Shares after
- 29,240
- Date
- 08 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,240
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.
Footnote F2
One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.